Skip to main content
The Maple Markets

Canadian Securities Exchange (CSE) · BETR.CN · ISIN CA08772P2026

BetterLife Pharma Inc.

0.3300 CAD

0.03(8.33%)down

Previous close · Sep 18, 15:59 ET

Data last updated: (18 h ago)· Delayed exchange data

Sign in to add to portfolio

BetterLife Pharma Inc. (BETR.CN) trades on the Canadian Securities Exchange and operates in the Biotechnology industry. Its market capitalisation is approximately 55.04M CAD. The company reports around 4 employees. Its ISIN is CA08772P2026. This page shows the latest available price, the day and 52-week ranges and an interactive chart. Quotes are delayed and are not intended for order execution.

Checking today's session…

Key facts

Exchange

Canadian Securities Exchange (CSE)

ISIN

CA08772P2026

Sector

Healthcare

Industry

Biotechnology

Country

CA

Market cap

53.42M CAD

Employees

4

Previous close

0.36 CAD

Day range

0.33 – 0.36

52-week range

0.04 – 0.46

Volume

248.62K

50-day average

0.29 CAD

200-day average

0.12 CAD

Asset type

Equity

About BetterLife Pharma Inc.

BetterLife Pharma Inc. is a biotechnology company focused on the global development and commercialization of therapeutic compounds, particularly for neurological disorders. The firm also innovates drug candidates utilizing complementary interferon-based technologies, designed to engage the immune system in combating viral infections. Its active development pipeline includes BETR-001, intended for major depressive disorder, treatment-resistant depression, cluster headaches, and post-traumatic stress disorder. Another key asset, BETR-002, is being advanced to address benzodiazepine dependency, anxiety, and spasticity. Further in development are MM-003 for COVID-19 and other respiratory viral infections; MM-001, a topical intravaginal cream for HPV-induced cervical intraepithelial neoplasia; and AP-002, designated for cancer treatment. BetterLife Pharma Inc. maintains a research collaboration with the University of California San Diego, focusing on preclinical behavioral pharmacology studies of TD-0148A, a lysergic acid diethylamide derivative solution. Headquartered in Vancouver, Canada, the company was founded in 2002 and was formerly known as Pivot Pharmaceuticals Inc. before adopting the name BetterLife Pharma Inc. in December 2019.

Company website

Frequently asked

+
What is the BETR.CN share price today?
This page shows the latest available BetterLife Pharma Inc. (BETR.CN) price with its change against the prior close. Values are delayed or previous-close, not real-time.
+
Where is BetterLife Pharma Inc. listed?
BetterLife Pharma Inc. trades on the Canadian Securities Exchange under the symbol BETR.CN, ISIN CA08772P2026.
+
How large is BetterLife Pharma Inc.?
Its market capitalisation is approximately 55.04M CAD, based on the latest available price and share count from our data provider.

All BetterLife Pharma Inc. data comes from exchange and provider feeds for the Canadian Securities Exchange and is published for information, not as investment advice.

Real-time quotes are not licensed; prices are delayed or previous close, so they may lag the market by 15 minutes or a full session. Information only, not for trading. Where a figure is not covered by our licensed sources, the page says so rather than showing a substitute.

We use necessary cookies to run the site and, only with your permission, analytics cookies to understand what readers use. Cookie policy